Log In
Print
BCIQ
Print
Print this Print this
 

APD334

  Manage Alerts
Collapse Summary General Information
Company Arena Pharmaceuticals Inc.
DescriptionSphingosine 1-phosphate receptor 1 (S1PR1; S1P1; EDG1) agonist
Molecular Target Sphingosine 1-phosphate receptor 1 (S1PR1) (S1P1) (EDG1)
Mechanism of ActionSphingosine 1-phosphate (S1P) receptor agonist
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase I
Standard Indication Autoimmune (unspecified)
Indication DetailsTreat autoimmune diseases
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today